Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cleve Clin J Med. 1996 Jan-Feb;63(1):43-7.

Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?

Author information

  • 1Department of Radiology and Medicine, University of Cincinnati Hospital, OH 45267-0577, USA.

Abstract

It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.

PMID:
8590515
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk